Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis.
Choroidal neovascularization
High myopia
Lacquer cracks
Multistate models
Myopic maculopathy
Pathologic myopia
Risk factors of progression
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
08
04
2020
accepted:
06
06
2020
revised:
01
06
2020
pubmed:
22
6
2020
medline:
19
8
2021
entrez:
22
6
2020
Statut:
ppublish
Résumé
This study aims to determine the probability of progression of myopic maculopathy according to age. This is a longitudinal observational study of single-center retrospective cohort of Caucasian patients formed by 212 consecutive adults with high myopia. Main outcome measures were age, visual acuity (VA), refractive error (RE), follow-up time, and the macular status assessed at least 5 years apart according to the Meta-Analysis of Pathologic Myopia Study Group. The progression rate was calculated based on per 1000 eyes/year. Multistate models were fitted to identify the predictive factors and to calculate the most probable age of progression onset using the Aalen-Johansen estimator. We studied 220 eyes of 122 Caucasian patients. Mean age was 48.18 ± 14.1, mean follow-up 12.73 ± 5.81 years. One-hundred and fifty-two (69.1%) eyes progressed of category, and 96 (44%) worsened a mean of 0.3 logMAR units during follow-up. The progression rate was 32.21/1000 eyes/year. The probability of progressing increased with age; it was higher in women if there was a family history of myopia, worse VA, higher RE, or wide macular staphyloma. The probability of progressing from category 1 was > 0.6 after 70 years of age; from category 2, it was 0.7 after 70 years; and 0.5 from category 3 after 75 years. If choroidal neovascularization (CNV) appeared, this probability exceeded 0.7 between ages 45 and 55 for all categories. The progression rate is lower than in a Japanese series. The vision worsened with disease progression, and the probability of both happening increased after the age of 70-75. If CNV appears, the risk of progression is very high at the age of 45-55.
Identifiants
pubmed: 32564136
doi: 10.1007/s00417-020-04795-5
pii: 10.1007/s00417-020-04795-5
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-92Références
Ohno-Matsui K (2016) Pathologic myopia. Asia Pac J Ophthalmol (Phila) 5:415–423. https://doi.org/10.1097/APO.0000000000000230
doi: 10.1097/APO.0000000000000230
Curtin BJ (1977) The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc 75:67–86 PMID: 613534
pubmed: 613534
pmcid: 1311542
Ohno-Matsui K (2014) Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology 121:1798–1809. https://doi.org/10.1016/j.ophtha.2014.03.035
doi: 10.1016/j.ophtha.2014.03.035
pubmed: 24813630
Verkicharla PK, Ohno-Matsui K, Saw SM (2015) Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt 35:465–475. https://doi.org/10.1111/opo.12238
doi: 10.1111/opo.12238
pubmed: 26303444
Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, Yamazaki M, Meuer S, Ishibashi T, Yasuda M, Yamashita H, Sugano A, Wang JJ, Mitchell P, Wong TY, META-analysis for Pathologic Myopia (META-PM) Study Group (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159(877–883):e7. https://doi.org/10.1016/j.ajo.2015.01.022
doi: 10.1016/j.ajo.2015.01.022
Fang Y, Yokoi T, Nagaoka N, Shinohara K, Onishi Y, Ishida T, Yoshida T, Xu X, Jonas JB, Ohno-Matsui K (2018) Progression of myopic maculopathy during 18-year follow-up. Ophthalmology 125:863–877. https://doi.org/10.1016/j.ophtha.2017.12.005
doi: 10.1016/j.ophtha.2017.12.005
pubmed: 29371011
Hashemi H, Fotouhi A, Yekta A, Pakzad R, Ostadimoghaddam H, Khabazkhoob M (2018) Global and regional estimates of prevalence of refractive errors: systematic review and meta-analysis. J Curr Ophthalmol 30:3–22. https://doi.org/10.1016/j.joco.2017.08.009
doi: 10.1016/j.joco.2017.08.009
pubmed: 29564404
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123:1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006
doi: 10.1016/j.ophtha.2016.01.006
pubmed: 26875007
Grossniklaus HE, Green WR (1992) Pathologic findings in pathologic myopia. Retina 12:127–133. https://doi.org/10.1097/00006982-199212020-00009
doi: 10.1097/00006982-199212020-00009
pubmed: 1439243
Liu HH, Xu L, Wang YX, Wang S, You QS, Jonas JB (2010) Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study. Ophthalmology 117:1763–1768. https://doi.org/10.1016/j.ophtha.2010.01.020
doi: 10.1016/j.ophtha.2010.01.020
pubmed: 20447693
Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, Yasuzumi K, Nagaoka N, Saka N, Yoshida T, Tokoro T, Mochizuki M (2010) Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology 117(1595–1611):e1–e4. https://doi.org/10.1016/j.ophtha.2009.11.003
doi: 10.1016/j.ophtha.2009.11.003
Yan YN, Wang YX, Yang Y, Xu L, Xu J, Wang Q, Yang JY, Yang X, Zhou WJ, Ohno-Matsui K, Wei WB, Jonas JB (2018) Ten-year progression of myopic maculopathy: the Beijing Eye Study 2001–2011. Ophthalmology 125:1253–1263. https://doi.org/10.1016/j.ophtha.2018.01.035
doi: 10.1016/j.ophtha.2018.01.035
pubmed: 29602569
Choudhury F, Meuer SM, Klein R, Wang D, Torres M, Jiang X, McKean-Cowdin, Varma R, Chinese American Eye Study Group (2018) Prevalence and characteristics of myopic degeneration in an adult Chinese American population: the Chinese American Eye Study. Am J Ophthalmol 187:34–42. https://doi.org/10.1016/j.ajo.2017.12.010
doi: 10.1016/j.ajo.2017.12.010
pubmed: 29288031
Cumberland PM, Bountziouka V, Rahi JS (2018) Impact of varying the definition of myopia on estimates of prevalence and associations with risk factors: time for an approach that serves research, practice and policy. Br J Ophthalmol 102:1407–1412. https://doi.org/10.1136/bjophthalmol-2017-311557
doi: 10.1136/bjophthalmol-2017-311557
pubmed: 29437571
pmcid: 6173820
Schmoor C, Schumacher M, Finke J, Beyersmann J (2013) Competing risks and multistate models. Clin Cancer Res 19:12–21
doi: 10.1158/1078-0432.CCR-12-1619
Kumar A, Chawla R, Kumawat D, Pillay G (2017) Insight into high myopia and the macula. Indian J Ophthalmol 65:85–91. https://doi.org/10.4103/ijo.IJO_863_16
doi: 10.4103/ijo.IJO_863_16
pubmed: 28345561
pmcid: 5381305
Jabs DA (2005) Improving the reporting of clinical case series. Am J Ophthalmol 139:900–905. https://doi.org/10.1016/j.ajo.2004.12.009
doi: 10.1016/j.ajo.2004.12.009
pubmed: 15860297
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc Ser B 34:187–220 https://www.jstor.org/stable/2985181
Aalen OO, Johansen S (1978) An empirical transition matrix for nonhomogeneous Markov chains based on censored observations. Scand J Stat 5:141–150 https://www.jstor.org/stable/4615704
Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526. https://doi.org/10.1093/biomet/81.3.515
doi: 10.1093/biomet/81.3.515
Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80–115. https://doi.org/10.1016/j.preteyeres.2018.10.005
doi: 10.1016/j.preteyeres.2018.10.005
pubmed: 30391362
Vongphanit J, Mitchell P, Wang JJ (2002) Prevalence and progression of myopic retinopathy in an older population. Ophthalmology 109:70411. https://doi.org/10.1016/s0161-6420(01)01024-7
doi: 10.1016/s0161-6420(01)01024-7
Gozum N, Cakir M, Gucukoglu A, Sezen F (1997) Relationship between retinal lesions and axial length, age and sex in high myopia. Eur J Ophthalmol 7:277–282
doi: 10.1177/112067219700700313
Shih YF, Ho TC, Hsiao CK, Lin LL (2006) Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol 90:546–550. https://doi.org/10.1136/bjo.2005.081992
doi: 10.1136/bjo.2005.081992
pubmed: 16622083
pmcid: 1857055
Ohno-Matsui K, Alkabes M, Salinas C, Mateo C, Moriyama M, Cao K, Yoshida T (2017) Features of posterior staphylomas analyzed in wide-field fundus images in patients with unilateral and bilateral pathologic myopia. Retina 37:477–486. https://doi.org/10.1097/IAE.0000000000001327
doi: 10.1097/IAE.0000000000001327
pubmed: 27557083
Chang L, Pan CW, Ohno-Matsui K, Cheung GC, Gazzard G, Koh V, Hamzah H, Tai ES, Lim SC, Mitchell P, Young TL, Aung T, Wong TY, Saw SM (2013) Myopia-related fundus changes in Singapore adults with high myopia. Am J Ophthalmol 155(991–999):e1. https://doi.org/10.1016/j.ajo.2013.01.016
doi: 10.1016/j.ajo.2013.01.016
Jonas JB, Fang Y, Weber P, Ohno-Matsui K (2018) Parapapillary gamma and delta zones in high myopia. Retina 38:931–938. https://doi.org/10.1097/IAE.0000000000001650
doi: 10.1097/IAE.0000000000001650
pubmed: 28426626
Liang CL, Yen E, Su JY, Liu C, Chang TY, Park N, Wu MJ, Lee S, Flynn JT, Juo SH (2004) Impact of family history of high myopia on level and onset of myopia. Invest Ophthalmol Vis Sci 45:3446–3452. https://doi.org/10.1167/iovs.03-1058
doi: 10.1167/iovs.03-1058
pubmed: 15452048
Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581. https://doi.org/10.1016/s0161-6420(84)34116-1
doi: 10.1016/s0161-6420(84)34116-1
pubmed: 6084222
Farinha CL, Baltar AS, Nunes SG, Figueira JP, Pires IA, Cachulo ML, Silva RM (2014) Progression of myopic maculopathy after treatment of choroidal neovascularization. Ophthalmologica 231:211–220. https://doi.org/10.1159/000357290
doi: 10.1159/000357290
pubmed: 24662778
Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH (2019) Trends in the prevalence of myopia and myopic Maculopathy in a Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 60:2781–2786. https://doi.org/10.1167/iovs.19-26580
doi: 10.1167/iovs.19-26580
pubmed: 31260519
Ito-Ohara M, Seko Y, Morita H, Imagawa N, Tokoro T (1998) Clinical course of newly developed or progressive patchy chorioretinal atrophy in pathological myopia. Ophthalmologica 212:23–29. https://doi.org/10.1159/000027254
doi: 10.1159/000027254
pubmed: 9438580
Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A, Tokoro T, Mochizuki M (2003) Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 87:570–573. https://doi.org/10.1136/bjo.87.5.570
doi: 10.1136/bjo.87.5.570
pubmed: 12714395
pmcid: 1771643